XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Paid In Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Treasury Stock [Member]
Maximum Cash Obligation Related To ESOP Shares [Member]
Beginning Balance at Dec. 31, 2018 $ 334,882 $ 52,122 $ 371,848 $ (3,250) $ (36,968) $ (48,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of 1,468, 13,120, 87,959 and 105,542 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively 5,374 3,072     2,302  
Issuance 1,786, 1,861, 5,821, and 5,430 shares of common stock under the employee stock purchase plan for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively 325 325        
Unearned restricted stock compensation 572 572        
Forfeiture of 134, 3,188, 5,255 and 4,211 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively (262) (262)        
Share-based compensation 7 7        
Change related to ESOP shares (2,432)         (2,432)
Net income 33,705   33,705      
Cash dividends ($0.82 and $0.89 per share for 9 months ended September 30, 2019 and 2020, respectively) (7,657)   (7,657)      
Purchase of 8,209, 29,807, 83,606 and 112,407 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively (5,177)       (5,177)  
Other comprehensive income 4,498     4,498    
Ending Balance at Sep. 30, 2019 363,835 55,836 397,896 1,248 (39,843) (51,302)
Beginning Balance at Jun. 30, 2019 353,524 55,515 386,614 972 (39,352) (50,225)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of 1,468, 13,120, 87,959 and 105,542 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively 95 56     39  
Issuance 1,786, 1,861, 5,821, and 5,430 shares of common stock under the employee stock purchase plan for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively 102 102        
Unearned restricted stock compensation 165 165        
Forfeiture of 134, 3,188, 5,255 and 4,211 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively (8) (8)        
Share-based compensation 6 6        
Change related to ESOP shares (1,077)         (1,077)
Net income 11,282   11,282      
Purchase of 8,209, 29,807, 83,606 and 112,407 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively (530)       (530)  
Other comprehensive income 276     276    
Ending Balance at Sep. 30, 2019 363,835 55,836 397,896 1,248 (39,843) (51,302)
Beginning Balance at Dec. 31, 2019 375,211 55,943 409,509 1,415 (39,830) (51,826)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of 1,468, 13,120, 87,959 and 105,542 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively 6,815 4,005     2,810  
Issuance 1,786, 1,861, 5,821, and 5,430 shares of common stock under the employee stock purchase plan for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively 304 304        
Unearned restricted stock compensation (81) (81)        
Forfeiture of 134, 3,188, 5,255 and 4,211 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively (218) (218)        
Share-based compensation 19 19        
Change related to ESOP shares 4,931         4,931
Net income 30,216   30,216      
Cash dividends ($0.82 and $0.89 per share for 9 months ended September 30, 2019 and 2020, respectively) (8,324)   (8,324)      
Purchase of 8,209, 29,807, 83,606 and 112,407 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively (7,230)       (7,230)  
Other comprehensive income 5,616     5,616    
Ending Balance at Sep. 30, 2020 407,259 59,972 431,401 7,031 (44,250) (46,895)
Beginning Balance at Jun. 30, 2020 398,719 60,043 419,971 6,821 (42,787) (45,329)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of 1,468, 13,120, 87,959 and 105,542 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively 809 458     351  
Issuance 1,786, 1,861, 5,821, and 5,430 shares of common stock under the employee stock purchase plan for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively 104 104        
Unearned restricted stock compensation (474) (474)        
Forfeiture of 134, 3,188, 5,255 and 4,211 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively (166) (166)        
Share-based compensation 7 7        
Change related to ESOP shares (1,566)         (1,566)
Net income 11,430   11,430      
Purchase of 8,209, 29,807, 83,606 and 112,407 shares of common stock for 3 months ended September 30, 2019 and 2020 and the 9 months ended September 30, 2019 and 2020, respectively (1,814)       (1,814)  
Other comprehensive income 210     210    
Ending Balance at Sep. 30, 2020 $ 407,259 $ 59,972 $ 431,401 $ 7,031 $ (44,250) $ (46,895)